When amniocentesis was first introduced into clinical practice in the 1950s, it could only pick up very large genetic differences—specifically extra or missing chromosomes—and was generally only offered to patients over age 35 years. By the 1980s, screening tests were available to help patients decide whether to undergo prenatal diagnosis, and over the past decades those screening tests have become far more accurate and much more widely used. Meanwhile, scientists have gone far deeper than merely counting chromosomes, identifying very small ways in which one person’s genome differs from another’s. There is a strong push to apply this new knowledge throughout the reproductive process—to learn as much as possible about all embryos, fetuses, and babies, so that prospective parents can decide whether to transfer particular embryos, whether to continue particular pregnancies, and how to parent the babies they have. In deciding how to navigate the opportunities and responsibilities genomics offers, there is already some evidence that prospective parents ask themselves what a “good parent” would do. In this talk, I identify instances of the idea of “good parenting” in genomics research and describe how this concept is addressed in the bioethics literature. I then offer an interpretation of good parenting that accounts for the empowering nature of genomics but also the burdens that genomic technologies may bring and the value many parents report finding in the uncontrolled “gift” of their children.